Drug abuse potential of single oral doses of lorcaserin, compared with zolpidem, ketamine and placebo in recreational polydrug users

Trial Profile

Drug abuse potential of single oral doses of lorcaserin, compared with zolpidem, ketamine and placebo in recreational polydrug users

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Apr 2011

At a glance

  • Drugs Lorcaserin (Primary) ; Ketamine; Zolpidem
  • Indications Obesity; Pain; Sleep disorders
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 17 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top